Erratum: Effect of the Affordable Medicines Facility–malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data (The Lancet (2012) 380(9857) (1916–1926)(S0140673612617322)(10.1016/S0140-6736(12)61732-2));Effect of the Affordable Medicines Facility - Malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: A before-and-after analysis of outlet survey data

The Lancet

Volumn 380, Issue 9857, 2012, Pages 1916-1926

  Tougher, Sarah ^a   Ye, Yazoume ^b   Amuasi, John H ^c,d   Kourgueni, Idrissa A ^e,f   Thomson, Rebecca ^a,h   Goodman, Catherine ^a   Mann, Andrea G ^a   Ren, Ruilin ^b   Willey, Barbara A ^a   Adegoke, Catherine A ⁱ   Amin, Abdinasir ^b   Ansong, Daniel ^d,j   Bruxvoort, Katia ^a,h   Diallo, Diadier A ^a   Diap, Graciela ^g   Festo, Charles ^h   Johanes, Boniface ^h   Juma, Elizabeth ^m   Kalolella, Admirabilis ^h   Malam, Oumarou ^f   Mberu, Blessing ^k   Ndiaye, Salif ^l   Nguah, Samuel B ^d   Seydou, Moctar ^f   Taylor, Mark ^a,h,n   Rueda, Sergio Torres ^a   Wamukoya, Marilyn ^k   Arnold, Fred ^b   Hanson, Kara ^a   more..

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b ICF INTERNATIONAL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

^e Centre International D'Etudes et de Recherches sur les Populations Africaines   (Niger)

^f Institut National de la Statistique   (Niger)

^g Drugs for Neglected Diseases Initiative   (Switzerland)

^h IFAKARA HEALTH INSTITUTE   (Tanzania)

ⁱ Phar Mark Consultants   (Nigeria)

^j KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^k AFRICAN POPULATION AND HEALTH RESEARCH CENTER   (Kenya)

^l Centre de Recherche pour le De veloppment Humain   (Senegal)

^m KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

ⁿ UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ DERIVATIVE;

COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG QUALITY; HEALTH CARE AVAILABILITY; HEALTH SURVEY; HUMAN; MADAGASCAR; MALARIA; MONOTHERAPY; NIGER; NIGERIA; PRIORITY JOURNAL; PROFIT; REVIEW; TANZANIA;

EID: 84870293006     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)62246-7     Document Type: Erratum

References (33)

1. WHO. World Malaria Report 2010. Geneva: World Health Organization, 2010.
2. ACTwatch Group. ACTwatch Household Surveys (Democratic Republic of the Congo, Republic of Benin, Republic of Zambia). http://www.actwatch.info/results/ country-specific-evidence.php (accessed Oct 3, 2012).
3. Measure DHS. Demographic and Health Surveys (Malawi, Rwanda, Sao Tome and Principe, Senegal, Sierra Leone, United Republic of Tanzania, Zimbabwe). http://www.measuredhs.com (accessed Oct 3, 2012).
4. Measure DHS. Malaria Indicator Surveys (Angola, Kenya, Liberia, Madagascar, Nigeria, Uganda). http://www.childinfo.org/mics.html (accessed Oct 3, 2012).
5. Sabot OJ, Mwita A, Cohen JM, et al. Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania. PLoS One 2009; 4: e6857.
6. Dondorp AM, Yeung S, White L, et al. Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol 2010; 8: 272-80.
7. Arrow KJ, Panosian CB, Gelband H. Saving lives and buying time: economics of malaria drugs in an age of resistance. Washington DC: National Academies Press, 2004.
8. Kangwana BP, Kedenge SV, Noor AM, et al. The impact of retail-sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya: a cluster randomized controlled trial. PLoS Med 2011; 8: e1000437.
9. Talisuna A, Grewal P, Rwakimari JB, Mukasa S, Jagoe G, Banerji J. Cost is killing patients: subsidising effective antimalarials. Lancet 2009; 374: 1224-26.
10. Sabot O, Yeung S, Pagoni F, et al. Distribution of artemisinin-based combination therapies through private sector channels: lessons from four country case studies. Washington DC: Resources For The Future, 2009.
11. Yeung S, Patouillard E, Allen H, Socheat D. Socially-marketed rapid diagnostic tests and ACT in the private sector: ten years of experience in Cambodia. Malaria J 2011; 10: 243.
12. The Global Fund to Fight AIDS Tuberculosis and Malaria. Affordable Medicines Facility - malaria. Geneva; 2008.
13. Kamal-Yanni M. Affordable medicines facility for malaria: reasonable or rash? Lancet 2010; 375: 121.
14. Laxminarayan R, Gelband H. A global subsidy: key to affordable drugs for malaria? Health Aff2009; 28: 949-61.
15. Moon S, Pérez Casas C, Kindermans J-M, de Smet M, von Schoen-Angerer T. Focusing on quality patient care in the new global subsidy for malaria medicines. PLoS Med 2009; 6: e1000106.
16. Sabot O, Gordon M, Moonen B, Talisuna A, Amofah G. A path to an optimal future for the Affordable Medicines Facility - malaria. Health Policy Plan 2011; 26: 441-44.
17. Adeyi O, Atun R. Universal access to malaria medicines: innovation in financing and delivery. Lancet 2010; 376: 1869-71.
18. Government of India Department of Customs. Indian chemicals import/export database. The EximNet! BBS, Online Telcom Network Services, 2009.
19. Roll Back Malaria. Updated ACT prices under the Affordable Medicines Facility-malaria 1 March 2011 fact sheet. Geneva: Roll Back Malaria, 2011.
20. AMFm Independent Evaluation Team. Independent evaluation of phase 1 of the Affordable Medicines Facility - malaria (AMFm), multi-country independent evaluation report: final report. Calverton, Maryland and London: ICF International and London School of Hygiene and Tropical Medicine, 2012.
21. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: new guidance. London: Medical Research Council, 2008.
22. Shewchuk T, O'Connell KA, Goodman C, Hanson K, Chapman S, Chavasse D. The ACTwatch project: methods to describe anti-malarial markets in seven countries. Malaria J 2011; 10: 325.
23. O'Connell KA, Gatakaa H, Poyer S, et al. Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries. Malaria J 2011; 10: 326.
24. The Global Fund to fight AIDS, Tuberculosis and Malaria. Global fund quality assurance policy for pharmaceutical products. Geneva: Global Fund to Fight AIDS, Tuberculosis and Malaria, 2010.
25. Schäferhoff M, Yamey G Estimating benchmarks of success in the Affordable Medicines Facility - malaria phase 1. San Francisco: Evidence-to-Policy Initiative, University of California, 2010.
26. Yamey G, Schaferhoff M, Montagu D. Piloting the Affordable Medicines Facility-malaria: what will success look like? Bull World Health Organ 2012; 90: 452-60.
27. Yadav P, Cohen JL, Alphs S, et al. Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania. Malaria J 2012; 11: 299.
28. ACTwatch Group and Association Béninoise pour le Marketing Social (ABMS)/Benin. Outlet Survey Republic of Benin 2011 Survey Report. Washington DC: Population Services International, 2011.
29. ACTwatch Group and Society for Family Health (SFH)/Zambia. Outlet survey report Zambia, 2009. Washington DC: Population Services International, 2009.
30. ACTwatch Group and Society for Family Health (SFH)/Zambia. Outlet Survey Republic of Zambia 2011 Survey Report. Washington DC: Population Services International, 2011.
31. ACTwatch Group and Association Béninoise pour le Marketing Social (ABMS)/Benin. Outlet Survey Republic of Benin 2009 Survey Report. Washington DC: Population Services International, 2009.
32. ACTwatch Group and Population Services International (PSI)/Madagascar. Madagascar Outlet Survey 2008 Report. Washington DC: Population Services International, 2009.
33. ACTwatch Group and the Program for Accessible Health CEPU.Uganda Outlet Survey 2009 Report. Washington DC: Population Services International, 2009.